Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and Koch's Disease

atazanavir sulfate has been researched along with Koch's Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhavani, PK; Chandrasekaran, C; Hemanth Kumar, AK; Raja, K; Ramachandran, G; Srinivasan, R; Sudha, V; Swaminathan, S; Venkatesh, S1
Ambrose, P; Benson, CA; Devaraj, C; Ezhilarasi, C; Jenks, JD; Kumarasamy, N; Poongulali, S; Yepthomi, T1
Arikan, D; Bertz, R; Coumbis, J; Farajallah, A; Stonier, M; Wu, Y; Xu, X; Zhang, J; Zhu, L1
Blanco, JL; Gatell, JM; López-Púa, Y; Mallolas, J; Martínez, E; Nomdedeu, M; Sarasa, M; Soriano, A1
Acosta, EP; Agarwala, S; Alston-Smith, B; Bertz, R; Child, M; Gerber, JG; Haas, DW; Hosey, L; Kendall, MA; Koletar, SL; Zolopa, AR1

Trials

1 trial(s) available for atazanavir sulfate and Koch's Disease

ArticleYear
Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adolescent; Adult; Analysis of Variance; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Atazanavir Sulfate; Biotransformation; Drug Therapy, Combination; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Oligopeptides; Pyridines; Rifabutin; Ritonavir; Tuberculosis; Young Adult

2011

Other Studies

4 other study(ies) available for atazanavir sulfate and Koch's Disease

ArticleYear
Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients in India.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:12

    Topics: Adult; Antibiotics, Antitubercular; Atazanavir Sulfate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; India; Male; Microbial Sensitivity Tests; Oligopeptides; Polypharmacy; Pyridines; Rifabutin; Ritonavir; Tuberculosis

2013
Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:9

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Antibiotics, Antitubercular; Atazanavir Sulfate; Child; Child, Preschool; Coinfection; Dose-Response Relationship, Drug; Electronic Health Records; Female; HIV Infections; Humans; India; Infant; Male; Middle Aged; Retrospective Studies; Rifabutin; Ritonavir; Treatment Outcome; Tuberculosis; Young Adult

2016
Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
    HIV medicine, 2007, Volume: 8, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Area Under Curve; Atazanavir Sulfate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Male; Oligopeptides; Prospective Studies; Pyridines; Rifampin; Ritonavir; Tuberculosis

2007
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Atazanavir Sulfate; Biotransformation; Drug Interactions; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Rifampin; Tuberculosis

2007